Genovis AB Series B | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
8,912.10
8,252.10
13,268.50
18,541.90
22,867.30
Cost of Goods Sold (COGS) incl. D&A
26,113.50
30,472.60
32,546.20
39,109.50
30,518.40
Gross Income
17,201.40
22,220.50
19,277.70
20,567.60
7,651.10
SG&A Expense
141.50
-
-
-
-
EBIT
17,342.90
20,913.70
18,797.70
20,567.60
7,651.10
Unusual Expense
-
-
1,093.80
5,097.70
-
Non Operating Income/Expense
1,355.30
442.50
67.20
699.70
184.30
Interest Expense
-
16.00
34.10
131.90
90.90
Pretax Income
15,914.10
20,330.70
19,858.10
14,901.70
7,926.10
Income Tax
61.60
1,718.00
47.50
129.30
22.50
Consolidated Net Income
15,852.50
22,048.70
19,905.60
15,031.00
7,948.50
Net Income
15,852.50
22,048.70
19,905.60
15,031.00
7,948.50
Net Income After Extraordinaries
15,852.50
22,048.70
19,905.60
15,031.00
7,948.50
Net Income Available to Common
15,852.50
22,048.70
19,905.60
15,031.00
7,948.50
EPS (Basic)
0.76
0.71
0.62
0.32
0.14
Basic Shares Outstanding
20,878.10
31,078.90
31,832.60
46,589.50
58,692.50
EPS (Diluted)
0.76
0.70
0.63
0.32
0.14
Diluted Shares Outstanding
20,878.10
31,452.30
31,832.60
46,589.50
58,692.50
EBITDA
16,229.20
19,639.40
17,478.90
19,273.60
6,042.00
Other Operating Expense
-
1,306.80
480.00
-
-
Non-Operating Interest Income
73.40
156.50
0.40
0.30
0.30

About Genovis AB

View Profile
Address
Scheelevägen 2
Lund SN 220 07
Sweden
Employees -
Website http://www.genovis.com
Updated 09/14/2018
Genovis AB engages in the development and market of nanotechnology. It develops, produces and markets technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The company was founded by Inga Sarah Maria Fredriksson in 1999 and is headquartered in Lund, Sweden.